B-OM the placebo group wasn't required, the sample size is meaningless compared to data kept on OM occurrence rates. I read the messages on this board from negative posters that really are child like with zero substance. The B-OM trial was successful, and are approvable and worth a lot of $. It's clear to me IPIX is packaging B potential across many applications for Big Pharma suitors for a better deal. For Big Pharmas that may want to buy the Co., all the results will be needed before negotiations sre finalized whether it's one indication at a time, each platform or the entire package.
People here that are negative are talking themselves out of a great opportunity. I just played RIOT made some $$$. IPIX is much better opportunity than Blockchain. For shorters, and I've shorted a lot of Co's in the past. I would never short a Co. like IPIX. Let's say it goes to 0, you made 100%. I just don't see the fundamental case that supports that scenario. If it goes to $10 you make 1000%. So the hedgefund shorting this Co., and I know it well, can very well flip to the long side and start pumping for much larger returns than the current short opportunity.